Total Payments
$4,567
2024 Payments
$326.50
Companies
20
Transactions
155
Medicare Patients
2,206
Medicare Billing
$178,103
Payment Breakdown by Category
Food & Beverage$4,197 (91.9%)
Education$369.73 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,197 | 150 | 91.9% |
| Education | $369.73 | 5 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEO Pharma Inc. | $741.17 | 32 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $573.69 | 13 | $0 (2022) |
| Galderma Laboratories, L.P. | $428.08 | 6 | $0 (2019) |
| GENZYME CORPORATION | $350.10 | 17 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $329.22 | 14 | $0 (2024) |
| Lilly USA, LLC | $263.87 | 13 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $241.46 | 5 | $0 (2021) |
| Janssen Biotech, Inc. | $204.64 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $203.00 | 2 | $0 (2021) |
| Amgen Inc. | $201.67 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.50 | 19 | Incyte Corporation ($93.48) |
| 2023 | $707.62 | 24 | Sun Pharmaceutical Industries Inc. ($227.89) |
| 2022 | $856.03 | 32 | Regeneron Healthcare Solutions, Inc. ($248.84) |
| 2021 | $814.57 | 21 | Regeneron Healthcare Solutions, Inc. ($237.26) |
| 2020 | $219.40 | 12 | Regeneron Healthcare Solutions, Inc. ($87.59) |
| 2019 | $417.03 | 13 | Galderma Laboratories, L.P. ($153.56) |
| 2018 | $242.03 | 11 | LEO Pharma Inc. ($186.56) |
| 2017 | $983.55 | 23 | Galderma Laboratories, L.P. ($274.52) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.48 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Immunology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Dermatology | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Immunology | ||||||
| 07/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Immunology | ||||||
| 07/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Dermatology | ||||||
| 06/24/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: Dermatology | ||||||
| 04/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Dermatology | ||||||
| 03/11/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Immunology | ||||||
| 02/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.36 | General |
| Category: Dermatology | ||||||
| 02/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Immunology | ||||||
| 02/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Dermatology | ||||||
| 01/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Immunology | ||||||
| 01/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.32 | General |
| Category: Dermatology | ||||||
| 11/06/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Immunology | ||||||
| 10/26/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Dermatology | ||||||
| 10/16/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: DERMATOLOGY | ||||||
| 10/12/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Immunology | ||||||
| 09/18/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Dermatology | ||||||
| 08/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 586 | 835 | $73,372 | $50,532 |
| 2022 | 13 | 655 | 1,017 | $79,461 | $54,649 |
| 2021 | 9 | 538 | 858 | $97,984 | $44,224 |
| 2020 | 7 | 427 | 709 | $81,503 | $28,697 |
Total Patients
2,206
Total Services
3,419
Medicare Billing
$178,103
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 161 | $23,491 | $16,720 | 71.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 145 | $14,905 | $10,585 | 71.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 67 | 79 | $9,681 | $6,524 | 67.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $6,615 | $4,490 | 67.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 55 | 63 | $4,966 | $3,141 | 63.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 61 | 69 | $4,462 | $2,943 | 66.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $4,057 | $2,219 | 54.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 33 | $2,005 | $1,470 | 73.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 43 | 199 | $1,610 | $1,222 | 75.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $1,581 | $1,218 | 77.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 174 | $18,229 | $12,718 | 69.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 98 | $14,379 | $9,710 | 67.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 63 | 75 | $9,219 | $6,443 | 69.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $7,100 | $4,885 | 68.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 101 | $6,651 | $4,638 | 69.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 75 | 94 | $7,784 | $4,383 | 56.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $3,671 | $2,895 | 78.9% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 16 | 16 | $2,647 | $2,092 | 79.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 53 | 313 | $2,723 | $1,841 | 67.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 16 | 16 | $2,343 | $1,514 | 64.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 12 | 12 | $1,826 | $1,381 | 75.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 16 | 27 | $1,641 | $1,296 | 79.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 15 | 15 | $1,248 | $851.56 | 68.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 145 | 189 | $27,189 | $14,135 | 52.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 65 | $20,863 | $6,647 | 31.9% |
About Dr. Teresa Notari, MD
Dr. Teresa Notari, MD is a Dermatology healthcare provider based in Summit, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104998285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Notari, MD has received a total of $4,567 in payments from pharmaceutical and medical device companies, with $326.50 received in 2024. These payments were reported across 155 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,197).
As a Medicare-enrolled provider, Notari has provided services to 2,206 Medicare beneficiaries, totaling 3,419 services with total Medicare billing of $178,103. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Summit, NJ
- Active Since 11/14/2006
- Last Updated 08/09/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104998285
Products in Payments
- DUPIXENT (Biological) $923.79
- PICATO (Drug) $424.84
- Otezla (Drug) $337.45
- Winlevi (Drug) $329.22
- DUOBRII (Drug) $228.19
- EPIDUO FORTE (Drug) $221.99
- OPZELURA (Drug) $187.47
- TREMFYA (Drug) $160.51
- ADBRY (Biological) $158.76
- ENSTILAR (Drug) $143.91
- Veltin (Drug) $102.77
- TALTZ (Drug) $100.03
- OLUMIANT (Drug) $67.76
- Sotyktu (Drug) $66.74
- EUCRISA (Drug) $63.31
- RINVOQ (Biological) $51.94
- ELIDEL (Drug) $45.34
- REMICADE (Biological) $44.13
- SOOLANTRA (Drug) $40.59
- Xeomin (Biological) $24.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.